Identification of TLR2 and TLR4-induced microRNAs in human mesenchymal stem cells and their possible roles in regulating TLR signals

Molecular Medicine Reports

Volumn 13, Issue 6, 2016, Pages 4969-4980

  Wang, Xingbing ^a   Zhu, Yunxia ^a   Xu, Bo ^a   Wang, Jing ^a   Liu, Xin ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Human; Mesenchymal stem cells; MicroRNAs; Toll like receptors

Indexed keywords

LIPOPOLYSACCHARIDE; MICRORNA; MICRORNA 1; MICRORNA 125A 5P; MICRORNA 137; MICRORNA 154 3P; MICRORNA 15A 5P; MICRORNA 181A 5P; MICRORNA 181C 3P; MICRORNA 186 5P; MICRORNA 199A 3P; MICRORNA 199B 3P; MICRORNA 221 3P; MICRORNA 222 3P; MICRORNA 24 3P; MICRORNA 29A 3P; MICRORNA 30D 5P; MICRORNA 30E 5P; MICRORNA 323A 3P; MICRORNA 323B 3P; MICRORNA 335 5P; MICRORNA 337 3P; MICRORNA 361 5P; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PROTEIN KINASE B; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; LIPOPEPTIDE; MESSENGER RNA; PAM(3)CSK(4) PEPTIDE;

ARTICLE; BIOINFORMATICS; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL EXPANSION; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; GENE ONTOLOGY; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; BIOLOGY; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES; REPRODUCIBILITY; RNA INTERFERENCE;

CELLS, CULTURED; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; HUMANS; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MESENCHYMAL STROMAL CELLS; MICRORNAS; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84966470238     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.5197     Document Type: Article

References (62)

1. Yates LA, Norbury CJ and Gilbert RJ: The long and short of microRNA. Cell 153: 516-519, 2013.
2. Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233, 2009.
3. Fabian MR, Sonenberg N and Filipowicz W: Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379, 2010.
4. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999.
5. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, et al: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49, 2002.
6. Charbord P: Bone marrow mesenchymal stem cells: Historical overview and concepts. Hum Gene Ther 21: 1045-1056, 2010.
7. Oreffo RO, Cooper C, Mason C and Clements M: Mesenchymal stem cells: Lineage, plasticity and skeletal therapeutic potential. Stem Cell Rev 1: 169-178, 2005.
8. Hwa Cho H, Bae YC and Jung JS: Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 24: 2744-2752, 2006.
9. van den Berk LC, Jansen BJ, Siebers-Vermeulen KG, Netea MG, Latuhihin T, Bergevoet S, Raymakers RA, Kögler G, Figdor CC, Adema GJ and Torensma R: Toll-like receptor triggering in cord blood mesenchymal stem cells. J Cell Mol Med 13: 3415-3426, 2009.
10. Wang X, Cheng Q, Li L, Wang J, Xia L, Xu X and Sun Z: Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34+cells. Exp Cell Re 318: 196-206, 2012.
11. Benakanakere MR, Li Q, Eskan MA, Singh AV, Zhao J, Galicia JC, Stathopoulou P, Knudsen TB and Kinane DF: Modulation of TLR2 protein expression by MIR-105 in human oral keratinocytes. J Biol Chem 284: 23107-23115, 2009.
12. Quinn EM, Wang JH, O'Callaghan G and Redmond HP: MicroRNA-146a is upregulated by and negatively regulates TLR2 signaling. PLoS One 8: e62232, 2013.
13. O'Hara SP, Splinter PL, Gajdos GB, Trussoni CE, Fernandez-Zapico ME, Chen XM and LaRusso NF: NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection. J Biol Chem 285: 216-225, 2010.
14. Yang K, He YS, Wang XQ, Lu L, Chen QJ, Liu J, Sun Z and Shen WF: MIR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett 585: 854-860, 2011.
15. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA and Croce CM: Modulation of MIR-155 and MIR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179: 5082-5089, 2007.
16. Curtale G, Mirolo M, Renzi TA, Rossato M, Bazzoni F and Locati M: Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci USA 110: 11499-11504, 2013.
17. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA and Pierre P: MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA 106: 2735-2740, 2009.
18. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
19. Hwa Cho H, Bae YC and Jung JS: Role of toll-like receptors on human adipose-derived cells. Stem Cells 24: 2744-2752, 2006.
20. Pevsner-Fischer M, Morad V, Cohen-Sfady M, Rousso-Noori L, Zanin-Zhorov A, Cohen S, Cohen IR and Zipori D: Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109: 1422-1432, 2007.
21. Liotta F, Angeli R, Cosmi L, Filì L, Manuelli C, Frosali F, Mazzinghi B, Maggi L, Pasini A, Lisi V, et al: Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T cell modulatory activity by 634 impairing Notch signaling. Stem Cells 26: 279-289, 2008.
22. Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, Köppel A, Tolosa E, Hoberg M, Anderl J, Aicher WK, et al: Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells 27: 909-919, 2009.
23. Tomchuck SL, Zwezdaryk KJ, Coffelt SB, Waterman RS, Danka ES and Scandurro AB: Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 26: 99-107, 2008.
24. Romieu-Mourez R, François M, Boivin MN, Bouchentouf M, Spaner DE and Galipeau J: Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J Immunol 182: 7963-7973, 2009.
25. White NM, Bao TT, Grigull J, Youssef YM, Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, et al: miRNA profiling for clear cell renal cell carcinoma: Biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol 186: 1077-1083, 2011.
26. Ma J, Liu J, Wang Z, Gu X, Fan Y, Zhang W, Xu L, Zhang J and Cai D: NF-kappaB-dependent MicroRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1β induction. Mol Cancer 13: 40, 2014.
27. Laine SK, Alm JJ, Virtanen SP, Aro HT and Laitala-Leinonen TK: MicroRNAs MIR-96, MIR-124 and MIR-199a regulate gene expression in human bone marrow-derived mesenchymal stem cells. J Cell Biochem 113: 2687-2695, 2012.
28. Chen J, Liu Z and Yang Y: In vitro screening of LPS-induced miRNAs in leukocytes derived from cord blood and their possible roles in regulating TLR signals. Pediatr Res 75: 595-602, 2014.
29. Akiyama H: Control of chondrogenesis by the transcription factor Sox9. Mod Rheumatol 18: 213-219, 2008.
30. Lin EA, Kong L, Bai XH, Luan Y and Liu CJ: MIR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. J Biol Chem 284: 11326-11335, 2009.
31. Wu ZY, Lu L, Liang J, Guo XR, Zhang PH and Luo SJ: Keloid microRNA expression analysis and the influence of MIR-199a-5p on the proliferation of keloid fibroblasts. Genet Mol Res 13: 2727-2738, 2014.
32. Shi XE, Li YF, Jia L, Ji HL, Song ZY, Cheng J, Wu GF, Song CC, Zhang QL, Zhu JY and Yang GS: MicroRNA-199a-5p affects porcine preadipocyte proliferation and differentiation. Int J Mol Sci 15: 8526-8538, 2014.
33. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M and Rajewsky N: Combinatorial microRNA target predictions. Nat Genet 37: 495-500, 2005.
34. Feng Y, Cao JH, Li XY and Zhao SH: Inhibition of MIR-214 expression represses proliferation and differentiation of C2C12 myoblasts. Cell Biochem Funct 29: 378-383, 2011.
35. Yang TS, Yang XH, Wang XD, Wang YL, Zhou B and Song ZS: MIR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN. Cancer Cell Int 13: 68, 2013.
36. Zhang ZC, Li YY, Wang HY, Fu S, Wang XP, Zeng MS, Zeng YX and Shao JY: Knockdown of MIR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma. PLoS One 9: e86149, 2014.
37. Derfoul A, Juan AH, Difilippantonio MJ, Palanisamy N, Ried T and Sartorelli V: Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase. Carcinogenesis 32: 1607-1614, 2011.
38. Brzezianska E and Pastuszak-Lewandoska D: A minireview: The role of MAPK/ERK and PI3K/Akt pathways in thyroid follicular cell-derived neoplasm. Front Biosci (Landmark Ed) 16: 422-439, 2011.
39. Nahid MA, Yao B, Dominguez-Gutierrez PR, Kesavalu L, Satoh M and Chan EK: Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modulation by MIR-132 and MIR-212. J Immunol 190: 1250-1263, 2013.
40. Ahmed F, Shiraishi T, Vessella RL and Kulkarni P: Tumor necrosis factor receptor associated factor-4: An adapter protein overexpressed in metastatic prostate cancer is regulated by microRNA-29a. Oncol Rep 30: 2963-2968, 2013.
41. Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, Visintin I, Leiser A, Schwartz PE, Rutherford T and Mor G: Regulation of IKKB by MIR-199a affects NF-kappB activity in ovarian cancer cells. Oncogene 27: 4712-4723, 2008.
42. Zhou R, O'Hara SP and Chen XM: MicroRNA regulation of innate immune responsesin epithelial cells. Cell Mol Immunol 8: 371-379, 2011.
43. Huang Z, Chen X, Yu B and Chen D: Cloning and functional characterization of rat stimulator of interferon genes (STING) regulated by MIR-24. Dev Comp Immunol 37: 414-420, 2012.
44. Lai NS, Yu HC, Chen HC, Yu CL, Huang HB and Lu MC: Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clin Exp Immunol 173: 47-57, 2013.
45. Zhao J, Gong AY, Zhou R, Liu J, Eischeid AN and Chen XM: Downregulation of PCAF by MIR-181a/b provides feedback regulation to TNF-α-induced transcription of proinflammatory genes in liver epithelial cells. J Immunol 188: 1266-1274, 2012.
46. Sharma A, Kumar M, Aich J, Hariharan M, Brahmachari SK, Agrawal A and Ghosh B: Posttranscriptional regulation of interleukin-10 expression by hsa-MIR-106a. Proc Natl Acad Sci USA 106: 5761-5766, 2009.
47. Zhang M, Liu Q, Mi S, Liang X, Zhang Z, Su X, Liu J, Chen Y, Wang M, Zhang Y, et al: Both MIR-17-5p and MIR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression. J Immunol 186: 4716-4724, 2011.
48. Witwer KW, Sisk JM, Gama L and Clements JE: MicroRNA regulation of IFN-beta protein expression: Rapid and sensitive modulation of the innate immune response. J Immunol 184: 2369-2376, 2010.
49. Lai L, Song Y, Liu Y, Chen Q, Han Q, Chen W, Pan T, Zhang Y, Cao X and Wang Q: MicroRNA-92a negatively regulates Toll-like receptor (TLR)-triggered inflammatory response in macrophages by targeting MKK4 kinase. J Biol Chem 288: 7956-7967, 2013.
50. Qi J, Qiao Y, Wang P, Li S, Zhao W and Gao C: MicroRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-κB1 in murine macrophages. FEBS Lett 586: 1201-1207, 2012.
51. Jennewein C, von Knethen A, Schmid T and Brüne B: MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization. J Biol Chem 285: 11846-11853, 2010.
52. Lu TX, Munitz A and Rothenberg ME: MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 182: 4994-5002, 2009.
53. Zhu QY, Liu Q, Chen JX, Lan K and Ge BX: MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J Immunol 185: 7435-7442, 2010.
54. Liu X, Zhan Z, Xu L, Ma F, Li D, Guo Z, Li N and Cao X: MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα. J Immunol 185: 7244-7251, 2010.
55. Ma F, Chen D, Chi Y, Chen F, Li X and Han Z: The expression and role of MIR-301a in human umbilical cord-derived mesenchymal stromal cells. Cytotherapy 15: 1511-1516, 2013.
56. Akira S, Uematsu S and Takeuchi O: Pathogen recognition and innate immunity. Cell 124: 783-801, 2006.
57. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L and Aderem A: The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97: 13766-13771, 2000.
58. Pasare C and Medzhitov R: Toll-like receptors: Linking innate and adaptive immunity. Adv Exp Med Biol 560: 11-18, 2005.
59. Hoebe K, Jiang Z, Georgel P, Tabeta K, Janssen E, Du X and Beutler B: TLR signaling pathways: Opportunities for activation and blockade in pursuit of therapy. Curr Pharm Des 12: 4123-4134, 2006.
60. Kawai T and Akira S: TLR signaling. Semin Immunol 19: 24-32, 2007.
61. O'Neill LA and Bowie AG: The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7: 353-364, 2007.
62. DelaRosa O and Lombardo E: Modulation of adult mesenchymal stem cells activity by toll-like receptors: Implications on therapeutic potential. Mediators Inflamm 2010: 865601, 2010.